Bimatoprost and Travoprost:
A Review of Recent Studies of Two New Glaucoma Drugs
To access this article, please choose from the options below
Supported by the an unrestricted grant from Research to Prevent Blindness, Inc., New York, NY. Dr. Camras is a Research to Prevent Blindness Senior Scientific Investigator, and a consultant to the Pharmacia Corporation. The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.
PII: S0039-6257(02)00327-2
© 2002 Elsevier Science Inc. All rights reserved.
